Newsroom

Recent news, statements, and resources

Newsroom

Recent news, statements, and resources

Welcome to The Leukemia & Lymphoma Society Newsroom

Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.

FDA-Approval-Leukemia

FDA Approves New Targeted Treatment for Acute Myeloid Leukemia

July 25, 2023

The Leukemia & Lymphoma Society’s 31st Annual Scenic Shore 150 Bike Tour Set to Ride the Shore for a Cure

July 18, 2023

National Visionary of the Year

When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive

July 13, 2023

We Made the List

The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category

July 10, 2023

FDA approves drug to treat most common form of lymphoma

Latest FDA Approval Joins a Torrent of New Treatments for Aggressive Lymphoma Subtype

July 10, 2023

FDA Approval

FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype

July 7, 2023

columns

37 Patient Organizations Applaud Proposed Rule to Rein in Short-Term Health Plans

July 7, 2023

people talking

THE LEUKEMIA & LYMPHOMA SOCIETY (LLS) INVESTS $3.8 MILLION TO ADVANCE HEALTH EQUITY

July 4, 2023

breaking news

The Leukemia & Lymphoma Society Welcomes Five Members to Board of Directors

July 1, 2023

Media Requests

For all media-related inquiries and interview requests please email [email protected]. An LLS representative will respond as soon as possible.